Domine Gomez, Manuel manuel.domine@uam.es
Actividades
- Artículos 38
- Libros 1
- Capítulos de libro 0
- Congresos 0
- Documentos de trabajo 0
- Informes técnicos 0
- Proyectos de investigación 0
- Tesis dirigidas 0
- Patentes o licencias de software 0
Tratamiento médico del carcinoma microcítico de pulmón. Carcinoma microcítico de pulmón
- Dómine Gómez, Manuel
- López-Vilariño de Ramos, José Antonio
- Ramírez Merino, Natalia
- Fuentes Mateos, Raquel
- Lobo Samper, Francisco
Revisiones En Cancer (p. 237-246) - 1/1/2009
- ISSN 02138573
- iMarina
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
- Arriola, E
- Gonzalez-Cao, M
- Domine, M
- De Castro, J
- Cobo, M
- Bernabe, R
- Navarro, A
- Sullivan, I
- Trigo, JM
- Mosquera, J
- Crama, L
- Isla, D
Oncology And Therapy (p. 167-184) - 1/6/2022
10.1007/s40487-021-00182-0 Ver en origen
- ISSN 23661089
Extensive pleural effusion as first manifestation of wall rhabdomyosarcoma
- Casal Rubio J
- Domine Gomez M
- Lopez Sacconi F
- Jerves Andrade M
- Vicente J
Oncologia (p. 403-408) - 1/1/1988
- ISSN 03784835
- iMarina
Anatomopathologic, clinical and therapeutic considerations on malignant tumors of the parotid. Our experience
- Arias de la Vega F
- Albert Solis J
- Perez Casas A
- Martinez Lopez E
- Domine Gomez M
- Melchor Iniguez M
Oncologia (p. 145-151) - 1/1/1988
- ISSN 03784835
- iMarina
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
- Sanchez-Herrero, Estela
- Serna-Blasco, Roberto
- Ivanchuk, Vadym
- Garcia-Campelo, Rosario
- Gomez, Manuel Domine
- Sanchez, Jose M.
- Massuti, Bartomeu
- Reguart, Noemi
- Camps, Carlos
- Sanz-Moreno, Sandra
- Calabuig-Farinas, Silvia
- Jantus-Lewintre, Eloisa
- Arnal, Magdalena
- Fernandez-Orth, Dietmar
- Calvo, Virginia
- Gonzalez-Rumayor, Victor
- Provencio, Mariano
- Romero, Atocha;
Molecular Oncology (p. 2363-2376) - 1/9/2021
10.1002/1878-0261.13033 Ver en origen
- ISSN 15747891
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
- de la Rosa, CA
- Castellanos, PC
- Lazaro-Quintela, M
- Domine, M
- Estevez, SV
- Lopez-Vivanco, G
- Perez, JLF
- Romero, JLA
- Delgado, LF
- Giron, CG
- Tain, PD
- Alvarez, RA
- Sanchis, PM
- Canton, IF
- Abos, IM
- Aguillo, MM
- Gutierrez, LGA
- Granados, ALO
- Cabellos, RA
- Sebastian, AG
- Sifuentes, LFG
- Reguart, N
Lung Cancer (p. 83-93) - 1/11/2022
10.1016/j.lungcan.2022.09.010 Ver en origen
- ISSN 01695002
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
- Aix SP
- Ciuleanu TE
- Navarro A
- Cousin S
- Bonanno L
- Smit EF
- Chiappori A
- Olmedo ME
- Horvath I
- Grohé C
- Farago AF
- López-Vilariño JA
- Cullell-Young M
- Nieto A
- Vasco N
- Gómez J
- Kahatt C
- Zeaiter A
- Carcereny E
- Roubec J
- Syrigos K
- Lo G
- Barneto I
- Pope A
- Sánchez A
- Kattan J
- Zarogoulidis K
- Waller CF
- Bischoff H
- Juan-Vidal O
- Reinmuth N
- Dómine M
- Paz-Ares L
Lancet Respiratory Medicine (p. 74-86) - 1/1/2023
10.1016/s2213-2600(22)00309-5 Ver en origen
- ISSN 22132600
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
- Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüro?lu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Ka?arnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L, CASPIAN investigators
Lancet Oncology (p. 51-65) - 1/1/2021
10.1016/s1470-2045(20)30539-8 Ver en origen
- ISSN 14702045
First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study
- Provencio-pulla, M
- Ortega, AL
- Coves, J
- Franco, F
- Marse, R
- Domine, M
- Guirado, M
- Carcereny, E
- Fernandez, N
- Martinez, E
- Blanco, R
- Leon, L
- Sanchez, JM
- Sullivan, I
- Cobo, M
- Sanchez, A
- Massuti, B
Journal Of Thoracic Oncology (p. S123-S124) - 1/9/2022
- ISSN 15560864
- iMarina
Multidisciplinary Thoracic Tumors Board Survey in Spain
- Massuti, B
- Nadal, E
- Camps, C
- Carcereny, E
- Cobo, M
- Domine, M
- Garcia-Campelo, MR
- Gonzalez-Larriba, JL
- Guirado, M
- Hernando-Trancho, F
- Rodriguez-Abreu, D
- Sanchez, A
- Sullivan, I
- Provencio, M
Journal Of Thoracic Oncology (p. S107-S107) - 1/9/2022
- ISSN 15560864
- iMarina
Este/a investigador/a no tiene capítulos de libro.
Este/a investigador/a no tiene congresos.
Este/a investigador/a no tiene documentos de trabajo.
Este/a investigador/a no tiene informes técnicos.
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene tesis dirigidas.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id